Eli Lilly

News

Lilly chases Amgen with migraine drug filing

Eli Lilly has filed its galcanezumab migraine drug with the FDA, as it looks to claim second place among a group of companies attempting to market a new class of therapies.

News

Novartis aims to broaden use of breast cancer drug

Study shows Kisqali extends survival in younger women with aggressive disease

News

Novo aiming for blockbuster sales for FDA-approved semagluti...

Novo Nordisk’s weekly GLP-1 diabetes injection semaglutide has been approved by the US regulator, a potential blockbuster that the firm hopes will allow it to regain market share from Lilly

News